node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
all1473 | alr4921 | gene:10493487 | gene:10496976 | ORF_ID:all1473; unknown protein. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.916 |
all1473 | ruvC | gene:10493487 | gene:10494326 | ORF_ID:all1473; unknown protein. | Holliday junction resolvase; Nuclease that resolves Holliday junction intermediates in genetic recombination. Cleaves the cruciform structure in supercoiled DNA by nicking to strands with the same polarity at sites symmetrically opposed at the junction in the homologous arms and leaves a 5'-terminal phosphate and a 3'-terminal hydroxyl group (By similarity). | 0.916 |
alr1158 | alr4921 | gene:10493172 | gene:10496976 | Mini-ribonuclease 3; Involved in correct processing of both the 5' and 3' ends of 23S rRNA precursor. Processes 30S rRNA precursor transcript even in absence of ribonuclease 3 (Rnc); Rnc processes 30S rRNA into smaller rRNA precursors; Belongs to the MrnC RNase family. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.410 |
alr1468 | alr4921 | gene:10493482 | gene:10496976 | CRISPR-associated endonuclease Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.883 |
alr3230 | alr4921 | gene:10495268 | gene:10496976 | 4-diphosphocytidyl-2C-methyl-D-erythritol kinase; Catalyzes the phosphorylation of the position 2 hydroxy group of 4-diphosphocytidyl-2C-methyl-D-erythritol. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.424 |
alr4919 | alr4921 | gene:10496974 | gene:10496976 | ORF_ID:alr4919; unknown protein. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.664 |
alr4919 | alr4922 | gene:10496974 | gene:10496977 | ORF_ID:alr4919; unknown protein. | ORF_ID:alr4922; unknown protein. | 0.911 |
alr4919 | asr4920 | gene:10496974 | gene:10496975 | ORF_ID:alr4919; unknown protein. | ORF_ID:asr4920; unknown protein. | 0.664 |
alr4921 | all1473 | gene:10496976 | gene:10493487 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | ORF_ID:all1473; unknown protein. | 0.916 |
alr4921 | alr1158 | gene:10496976 | gene:10493172 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | Mini-ribonuclease 3; Involved in correct processing of both the 5' and 3' ends of 23S rRNA precursor. Processes 30S rRNA precursor transcript even in absence of ribonuclease 3 (Rnc); Rnc processes 30S rRNA into smaller rRNA precursors; Belongs to the MrnC RNase family. | 0.410 |
alr4921 | alr1468 | gene:10496976 | gene:10493482 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | CRISPR-associated endonuclease Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.883 |
alr4921 | alr3230 | gene:10496976 | gene:10495268 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 4-diphosphocytidyl-2C-methyl-D-erythritol kinase; Catalyzes the phosphorylation of the position 2 hydroxy group of 4-diphosphocytidyl-2C-methyl-D-erythritol. | 0.424 |
alr4921 | alr4919 | gene:10496976 | gene:10496974 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | ORF_ID:alr4919; unknown protein. | 0.664 |
alr4921 | alr4922 | gene:10496976 | gene:10496977 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | ORF_ID:alr4922; unknown protein. | 0.620 |
alr4921 | asr4920 | gene:10496976 | gene:10496975 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | ORF_ID:asr4920; unknown protein. | 0.773 |
alr4921 | mazE | gene:10496976 | gene:10495250 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | Cell growth regulatory protein; ORF_ID:asl3212; mazE gene product. | 0.781 |
alr4921 | psbB | gene:10496976 | gene:10492143 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | Photosystem II CP47 protein; One of the components of the core complex of photosystem II (PSII). It binds chlorophyll and helps catalyze the primary light- induced photochemical processes of PSII. PSII is a light-driven water:plastoquinone oxidoreductase, using light energy to abstract electrons from H(2)O, generating O(2) and a proton gradient subsequently used for ATP formation; Belongs to the PsbB/PsbC family. PsbB subfamily. | 0.534 |
alr4921 | ruvC | gene:10496976 | gene:10494326 | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | Holliday junction resolvase; Nuclease that resolves Holliday junction intermediates in genetic recombination. Cleaves the cruciform structure in supercoiled DNA by nicking to strands with the same polarity at sites symmetrically opposed at the junction in the homologous arms and leaves a 5'-terminal phosphate and a 3'-terminal hydroxyl group (By similarity). | 0.762 |
alr4922 | alr4919 | gene:10496977 | gene:10496974 | ORF_ID:alr4922; unknown protein. | ORF_ID:alr4919; unknown protein. | 0.911 |
alr4922 | alr4921 | gene:10496977 | gene:10496976 | ORF_ID:alr4922; unknown protein. | mRNA interferase; Toxic component of a type II toxin-antitoxin (TA) system. | 0.620 |